The global medical health screening market size was USD 26.62 billion in 2023, calculated at USD 28.09 billion in 2024 and is expected to be worth around USD 48.07 billion by 2034. The market is slated to expand at 5.52% CAGR from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Health Screening Market
5.1. COVID-19 Landscape: Medical Health Screening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Health Screening Market, By Test Type
8.1. Medical Health Screening Market, by Test Type, 2024-2034
8.1.1. Routine Tests
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Non-routine Tests
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cancer Screening Tests
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Speciality Tests
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Medical Health Screening Market, By Setting Type
9.1. Medical Health Screening Market, by Setting Type, 2024-2034
9.1.1. Hospitals/Clinical Laboratories
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Workplaces
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Ambulatory Care Centers
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Multi-Speciality Clinics
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Diagnostic Imaging Centers
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Medical Health Screening Market, By Sample Type
10.1. Medical Health Screening Market, by Sample Type, 2024-2034
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Urine
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Saliva
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Medical Health Screening Market, By End-user
11.1. Medical Health Screening Market, by End-user, 2024-2034
11.1.1. Hospitals/Clinics Diagnostic Laboratories
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Workplaces
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Research Institutes
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Medical Health Screening Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.1.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.1.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.2.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.2.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.3.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.3.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.4.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Test Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Setting Type (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-user (2021-2034)
Chapter 13. Company Profiles
13.1. LifeLabs
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Healthscope
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Clinical Reference Laboratory
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ACM Medical Laboratory
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Unilabs
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. LabCorp
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sonic Healthcare
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. SYNLAB International
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Eurofins Scientific
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Quest Diagnostics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample